0049 711 685-66989
0049 711 685-67484
Roland Kontermann received his PhD in molecular biology from the University of Heidelberg in 1992. From 1993-1996 he was a postdoctoral research fellow in Sir Gregory Winter’s laboratory at the MRC Centre for Protein Engineering in Cambridge (UK) where he started his work in the field of recombinant antibodies and phage display technology. From 1996-2000 he was a group leader at the Institute of Molecular Biology and Tumor Research (IMT) at the University of Marburg, where he also obtained his habilitation in molecular biology. Between 2001 and 2004 he was head of biotechnology and later on head of research of a co-founded Biotech company working in the field of targeted drug delivery systems. In 2004 he was appointed Professor of Biomedical Engineering at the Institute of Cell Biology and Immunology (University of Stuttgart), endowed until 2014 by the Deutsche Krebshilfe. Current research interests focus on the development of recombinant antibodies and bispecific and bifunctional antibody fusion proteins with improved biological and pharmacokinetic properties for cancer therapy and other indications.